Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification
Eiso Hiyama(Hiroshima University), Megu Ohtaki(Hiroshima University), Satoshi Kondo(Hokkaido University), Fumiaki Sasaki(Hokkaido University), Masahiko Sugiyama, Akihiro Yoneda(Ministry of Health Labour and Welfare), Masahiro Fukuzawa(The University of Osaka), Tatsuro Tajiri(Kyushu University), Hiroaki Yamaoka(Hiroshima University Hospital), Yutaka Hayashi(Juntendo University)
Cited by 4
Related Papers
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749
Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus
|World Journal of Surgery|1990|506
Apparent Diffusion Coefficient of Human Brain Tumors at MR Imaging
|Radiology|2005|505
The Pattern of Infiltration at the Proximal Border of Hilar Bile Duct Carcinoma
|Annals of Surgery|1998|276